Literature DB >> 16430375

Early, transient increase in complexin I and complexin II in the cerebral cortex following traumatic brain injury is attenuated by N-acetylcysteine.

Jae-Hyuk Yi1, Rachel Hoover, Tracy K McIntosh, Alan S Hazell.   

Abstract

Alteration of excitatory neurotransmission is a key feature of traumatic brain injury (TBI) in which extracellular glutamate levels rise. Although increased synaptic release of glutamate occurs at the injury site, the precise mechanism is unclear. Complexin I and complexin II constitute a family of cytosolic proteins involved in the regulation of neurotransmitter release, competing with the chaperone protein alpha-SNAP (soluble N-ethylmaleimide-sensitive factor-attachment protein) for binding to the synaptic vesicle protein synaptobrevin as well as the synaptic membrane proteins SNAP-25 and syntaxin, which together form the SNAP receptor (SNARE) complex. Complexin I is predominantly a marker of axosomatic (inhibitory) synapses, whereas complexin II mainly labels axodendritic and axospinous synapses, the majority of which are excitatory. In order to examine the role of these proteins in TBI, we have studied levels of both complexins in the injured hemisphere by immunoblotting over a time period ranging from 6 h to 7 days following lateral fluid-percussion brain injury in the rat. Transient increases in the levels of complexin I and complexin II proteins were detected in the injured cerebral cortex 6 h following TBI. This increase was followed by a decrease of complexin I in the injured cortex and hippocampus, and a decrease in both complexins in the injured thalamus region at day 3 and day 7 post-injury. The early, transient increase in the injured cortex was completely blocked by N-acetylcysteine (NAC) administered 5 min following trauma, suggesting an involvement of oxidative stress. Neuronal loss was also reduced in the injured hemisphere with post-TBI NAC treatment. Our findings suggest a dysregulation of both inhibitory and excitatory neurotransmission following traumatic injury that is responsive to antioxidant treatment. These alterations in complexin levels may also play an important role in neuronal cell loss following TBI, and thus contribute to the pathophysiology of cerebral damage following brain injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430375     DOI: 10.1089/neu.2006.23.86

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  14 in total

Review 1.  Hemorrhagic progression of a contusion after traumatic brain injury: a review.

Authors:  David Kurland; Caron Hong; Bizhan Aarabi; Volodymyr Gerzanich; J Marc Simard
Journal:  J Neurotrauma       Date:  2011-12-05       Impact factor: 5.269

2.  Traumatic Brain Injury Impairs Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein Receptor Complex Formation and Alters Synaptic Vesicle Distribution in the Hippocampus.

Authors:  Shaun W Carlson; Hong Yan; Michelle Ma; Youming Li; Jeremy Henchir; C Edward Dixon
Journal:  J Neurotrauma       Date:  2015-08-27       Impact factor: 5.269

3.  N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI.

Authors:  Jignesh D Pandya; Ryan D Readnower; Samir P Patel; Heather M Yonutas; James R Pauly; Glenn A Goldstein; Alexander G Rabchevsky; Patrick G Sullivan
Journal:  Exp Neurol       Date:  2014-05-01       Impact factor: 5.330

Review 4.  Better together? Treating traumatic brain injury with minocycline plus N-acetylcysteine.

Authors:  Siobhán Lawless; Peter J Bergold
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

5.  N-acetyl-L-cysteine protects against cadmium-induced neuronal apoptosis by inhibiting ROS-dependent activation of Akt/mTOR pathway in mouse brain.

Authors:  Sujuan Chen; Qian Ren; Jinfei Zhang; Yangjing Ye; Zhen Zhang; Yijiao Xu; Min Guo; Haiyan Ji; Chong Xu; Chenjian Gu; Wei Gao; Shile Huang; Long Chen
Journal:  Neuropathol Appl Neurobiol       Date:  2014-10       Impact factor: 8.090

6.  Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases.

Authors:  Chien-Liang Glenn Lin; Qiongman Kong; Gregory D Cuny; Marcie A Glicksman
Journal:  Future Med Chem       Date:  2012-09       Impact factor: 3.808

7.  Tensor-based morphometry and stereology reveal brain pathology in the complexin1 knockout mouse.

Authors:  Catherine Kielar; Stephen J Sawiak; Paloma Navarro Negredo; Desmond H Y Tse; A Jennifer Morton
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

8.  Rgcs1, a dominant QTL that affects retinal ganglion cell death after optic nerve crush in mice.

Authors:  Joel A Dietz; Yan Li; Lisa M Chung; Brian S Yandell; Cassandra L Schlamp; Robert W Nickells
Journal:  BMC Neurosci       Date:  2008-07-31       Impact factor: 3.288

9.  Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine.

Authors:  Gang Chen; Jixin Shi; Zhigang Hu; Chunhua Hang
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

10.  Effects of antioxidant treatment on blast-induced brain injury.

Authors:  Xiaoping Du; Donald L Ewert; Weihua Cheng; Matthew B West; Jianzhong Lu; Wei Li; Robert A Floyd; Richard D Kopke
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.